| | |
| Clinical data | |
|---|---|
| Other names | 2-MPEA; ortho-Methoxyphenethylamine; o-Methoxyphenethylamine |
| Drug class | Trace amine-associated receptor 1 (TAAR1) agonist |
| ATC code |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.016.425 |
| Chemical and physical data | |
| Formula | C9H13NO |
| Molar mass | 151.209 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
2-Methoxyphenethylamine (2-MPEA) is a drug of the phenethylamine family. [1] It is one of the methoxyphenethylamine positional isomers. [1]
The effects of 2-MPEA in humans have not been reported and are unknown. [1]
The drug showed very low affinity for the serotonin receptors in the rat stomach fundus strip (A2 = 3,020 nM). [1] [2] In another study, it showed no affinity for the serotonin 5-HT2A or 5-HT2C receptors (Ki = >10,000 nM). [3] 2-MPEA is a potent full agonist of the human trace amine-associated receptor 1 (TAAR1) (EC50 = 144 nM; Emax = 95%). [4]
2-MPEA was first described in the scientific literature by at least 1943. [5] [6] [1] It was included as an entry in Alexander Shulgin's 2011 book The Shulgin Index, Volume One: Psychedelic Phenethylamines and Related Compounds . [1]